133 related articles for article (PubMed ID: 18227145)
1. Identification of a novel glucosylsulfate conjugate as a metabolite of 3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501, beta-lapachone) in mammals.
Savage RE; Tyler AN; Miao XS; Chan TC
Drug Metab Dispos; 2008 Apr; 36(4):753-8. PubMed ID: 18227145
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of beta-lapachone (ARQ 501) in mammalian hepatocytes and cultured human cells.
Miao XS; Zhong C; Wang Y; Savage RE; Yang RY; Kizer D; Volckova E; Ashwell MA; Chan TC
Rapid Commun Mass Spectrom; 2009 Jan; 23(1):12-22. PubMed ID: 19051226
[TBL] [Abstract][Full Text] [Related]
3. Identification of the in vitro metabolites of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (ARQ 501; beta-lapachone) in whole blood.
Miao XS; Song P; Savage RE; Zhong C; Yang RY; Kizer D; Wu H; Volckova E; Ashwell MA; Supko JG; He X; Chan TC
Drug Metab Dispos; 2008 Apr; 36(4):641-8. PubMed ID: 18180274
[TBL] [Abstract][Full Text] [Related]
4. Synthetic methods for the preparation of ARQ 501 (beta-Lapachone) human blood metabolites.
Yang RY; Kizer D; Wu H; Volckova E; Miao XS; Ali SM; Tandon M; Savage RE; Chan TC; Ashwell MA
Bioorg Med Chem; 2008 May; 16(10):5635-43. PubMed ID: 18424157
[TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism study of β-lapachone in mouse, rat, dog, monkey, and human liver microsomes using liquid chromatography-tandem mass spectrometry.
Lee S; Kim IS; Kwak TH; Yoo HH
J Pharm Biomed Anal; 2013 Sep; 83():286-92. PubMed ID: 23777616
[TBL] [Abstract][Full Text] [Related]
6. Involvement of NO/cGMP signaling in the apoptotic and anti-angiogenic effects of beta-lapachone on endothelial cells in vitro.
Kung HN; Chien CL; Chau GY; Don MJ; Lu KS; Chau YP
J Cell Physiol; 2007 May; 211(2):522-32. PubMed ID: 17192848
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ARQ 501 (beta-lapachone) in plasma and tumors from nu/nu mouse xenografts.
Savage RE; Hall T; Bresciano K; Bailey J; Starace M; Chan TC
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):148-53. PubMed ID: 18706870
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Boothman DA; Greer S; Pardee AB
Cancer Res; 1987 Oct; 47(20):5361-6. PubMed ID: 3652040
[TBL] [Abstract][Full Text] [Related]
9. Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones.
Frydman B; Marton LJ; Sun JS; Neder K; Witiak DT; Liu AA; Wang HM; Mao Y; Wu HY; Sanders MM; Liu LF
Cancer Res; 1997 Feb; 57(4):620-7. PubMed ID: 9044837
[TBL] [Abstract][Full Text] [Related]
10. Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2'-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites.
Peixoto JF; Oliveira ADS; Gonçalves-Oliveira LF; Souza-Silva F; Alves CR
Braz J Infect Dis; 2023; 27(2):102743. PubMed ID: 36731538
[TBL] [Abstract][Full Text] [Related]
11. Preparation of alpha-diazocarbonyl compounds from beta-lapachone derivatives and other 1,2-naphthoquinones: use of the 2D NMR 1H,15N and 1H,13C HMBC techniques in assigning regiochemistry.
Ferreira VF; Jorqueira A; Leal KZ; Pimentel HR; Seidl PR; da Silva MN; da Souza MC; Pinto AV; Wardell JL; Wardell SM
Magn Reson Chem; 2006 Apr; 44(4):481-90. PubMed ID: 16489549
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by beta-lapachone and related naphthoquinones.
Dubin M; Fernandez Villamil SH; Stoppani AO
Biochem Pharmacol; 1990 Apr; 39(7):1151-60. PubMed ID: 2157443
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi.
Goijman SG; Stoppani AO
Arch Biochem Biophys; 1985 Jul; 240(1):273-80. PubMed ID: 2409922
[TBL] [Abstract][Full Text] [Related]
14. Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity?
Gómez Castellanos JR; Prieto JM; Heinrich M
J Ethnopharmacol; 2009 Jan; 121(1):1-13. PubMed ID: 18992801
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
Yamashita M; Kaneko M; Tokuda H; Nishimura K; Kumeda Y; Iida A
Bioorg Med Chem; 2009 Sep; 17(17):6286-91. PubMed ID: 19674905
[TBL] [Abstract][Full Text] [Related]
16. Melanogenesis inhibition of β-lapachone, a natural product from Tabebuia avellanedae, with effective in vivo lightening potency.
Kim JH; Lee SM; Myung CH; Lee KR; Hyun SM; Lee JE; Park YS; Jeon SR; Park JI; Chang SE; Hwang JS
Arch Dermatol Res; 2015 Apr; 307(3):229-38. PubMed ID: 25663088
[TBL] [Abstract][Full Text] [Related]
17. STAT3 inhibitory activity of naphthoquinones isolated from Tabebuia avellanedae.
Tahara T; Watanabe A; Yutani M; Yamano Y; Sagara M; Nagai S; Saito K; Yamashita M; Ihara M; Iida A
Bioorg Med Chem; 2020 Mar; 28(6):115347. PubMed ID: 32044231
[TBL] [Abstract][Full Text] [Related]
18. beta-Lapachone: synthesis of derivatives and activities in tumor models.
Schaffner-Sabba K; Schmidt-Ruppin KH; Wehrli W; Schuerch AR; Wasley JW
J Med Chem; 1984 Aug; 27(8):990-4. PubMed ID: 6205152
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
Gong Q; Hu J; Wang P; Li X; Zhang X
Eur J Med Chem; 2021 Jan; 210():112962. PubMed ID: 33158575
[TBL] [Abstract][Full Text] [Related]
20. Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation.
Li X; Bian J; Wang N; Qian X; Gu J; Mu T; Fan J; Yang X; Li S; Yang T; Sun H; You Q; Zhang X
Bioorg Med Chem; 2016 Mar; 24(5):1006-13. PubMed ID: 26803578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
